InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease

Clinical trial NCT06059989 · RECRUITING

Trial details

NCT number: NCT06059989
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Inflammatory Disease Disease Crohn Bowel Disease

Start date: 2021-11-25
Primary completion: 2025-06-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.